Skip to content

Hamilton Lane

US · HLNE #2333 by market cap Listed 2017
81.07 -3.91 -4.60%
Periodic snapshot; not a real-time feed. · 2026-11-20 19:30

✦ Quant Fair Value how this is computed

Below fair value
103.24 fair value ≈ 150.36 197.47
  • Implied fair-value range of 103.24-197.47, from this stock's own trailing 5-year average P/E applied to trailing EPS.
  • Current price is -46.1% below the average-multiple fair value of 150.36.

Valuation each multiple against its own 5-year range

P/B ratio 4.11 Cheap vs history 6th percentile
5-year average 8.02 · #118 of 136 in Asset Management
P/E ratio 13.91 Cheap vs history 6th percentile
5-year average 25.40 · forward 10.25 · #39 of 80 in Asset Management
P/S ratio 4.73 Cheap vs history 5th percentile
5-year average 7.59 · forward 4.16 · #97 of 133 in Asset Management

Vs. peers Asset Management

Company Market cap P/E (TTM) P/B Div yield
Hamilton Lane (HLNE) 3.57B 12.03 3.56 2.81%
Blackrock (BLK) 170.13B 25.08 2.93 2.03%
Blackstone (BX) 87.61B 24.68 9.91 4.72%
Brookfield (BN) 84.27B 37.75 1.79 0.72%
KKR & Co (KKR) 78.99B 25.96 2.85 0.86%
Brookfield Asset Management (BAM) 78.20B 16.76 8.30 3.97%

Other StockVane-tracked companies in the same industry.

Morningstar

★★★☆☆ Fair value99.92 Economic moatNarrow UncertaintyMedium

Trading 23.2% below Morningstar's fair value estimate.

Fair value

Hamilton Lane Inc earns a 3-star quantitative star rating, indicating our belief that this share class is a balanced choice, but prudent investors should consider looking elsewhere. The stock currently trades at a 6% discount to our quantitative fair value estimate of $99.92 per share; however, some caution is warranted due to this estimate's medium uncertainty rating. We require the price/fair value ratio to move a certain amount before the star rating can change. This stability-enhancing buffer is in effect for this stock.

The firm's solid growth strengthens our estimated fair value. Consistent revenue and earnings growth indicates a company's potential for increased market share and profitability. Reflecting the firm's growth is its revenue 3-year growth of 24.0%, which sits in the top 20% globally. Robust trailing three-year revenue growth portends a favorable future trajectory, which contributes to our view that shares are undervalued.

On a different note, the firm's valuation metrics are potentially concerning. A company's valuation metrics provide insights into the market's expectations for its future growth and profitability. The firm's book value yield of 20.1%, a core component of valuation, sits in the bottom 20% compared with global peers. The market value of this company's shares looks expensive relative to the book (accounting) value of equity, which, despite our favorable price/fair value ratio, is a negative attribute.

In addition to the aforementioned drivers, our model considers momentum as part of its comprehensive analysis. This share class has been a laggard relative to the broader universe over the past year. This underperformance makes the stock appear cheap, which portends a buying opportunity in light of other contributors to our model.

Economic moat

The company's narrow quantitative moat rating indicates it could outearn its cost of capital and maintain robust margins for 10 years or longer. In addition, the company's moderate financial health score is decent and doesn't seriously concern us with regard to financial distress.

By Quantitative Equity Report

Quote time 2026-11-20 19:30:05 · For reference only, not investment advice and not tailored to your situation.

Hamilton Lane discussion 0 comments

Add a comment